Shensong Yangxin capsule reduces atrial fibrillation susceptibility by inhibiting atrial fibrosis in rats with post-myocardial infarction heart failure

PURPOSE: Shensong Yangxin (SSYX) capsule is a traditional Chinese medicine that has been used widely to treat cardiac arrhythmia. This study aimed to assess whether SSYX prevents atrial fibrillation (AF) after chronic myocardial infarction (MI)-induced heart failure and to determine the underlying m...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Drug Des Devel Ther
Главные авторы: Ma, Jin, Yin, Chunxia, Ma, Shiyu, Qiu, Huiliang, Zheng, Chaoyang, Chen, Qiuxiong, Ding, Chunhua, Lv, Weihui
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2018
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6186904/
https://ncbi.nlm.nih.gov/pubmed/30349194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S182834
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы